Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Dec 05, 2022 5:02pm
407 Views
Post# 35152013

RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval ...

RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval ...True enough gojotv but admittedly our fellow shareholders need to see that through a single or multiple JV will give them far more than that miniscule amount. Not that long ago I did a rough ultra conservative earning on only 10% I repeat 10% which came out to $19.50 a share. Easy calculation for 50% of the NMIBC  market would give you $97.50
 Let's take a hypothetical capture of a vaccine for Covid-19 would that with collaboration with Health Canada or JV with a pharmaceutical add maybe another $100 plus buck's or more to the share price? Let's not forget GBM, NSCLC think that might eventually add a few coins to revenue. Son of a gun gee gojotv you're right that is much better than 20.

gojotv! Wrote  
$20/share?!... Oh, ye of little balls! 
Feel free to sell into the market at $20 if you wish, but this is a $500 stock.
(Especially with our tiny, little share float, that's bound to split and split again as interest grows...)
And I don't mind holding out from Big Pharma to get it there.
The whole reason BTD and AA exist is that generations have dreamed of a CURE for cancer, and didn't want bureaucratic holdups when it arrived. 
They wanted to ensure we could save every single possible life we could as soon as a safe, viable cure appeared.
And TLD-1433 is it!
We have the approach to cancer treatment that will revolutionize oncology!
That kind of desirability is worth trillions, not billions. And we could re-start Canada's Pharma industry, keeping our young minds here, and encouraging education and interest in healthcare for generations to come...!
GLTA!



riverrrow wrote: When TLT gets bought out for $20 both Justine and the CRA will be very happy.  GLTA.




<< Previous
Bullboard Posts
Next >>